The Use of Off-label and Unlicensed Drugs for Neonates: A Report from a Teaching Hospital in Baghdad

Numan Nafie Hameed Hameed; Shealan Khudhair Abbas Abbas

doi:10.32007/jfacmedbagdad.6512014

Authors

Numan Nafie Hameed department of neonatal , college of medicine, university of Baghdad https://orcid.org/0000-0001-5987-1693
Shealan khudhair Abbas Pediatric Fellow, Children Welfare Teaching Hospital, Medical City Complex Baghdad

DOI:

https://doi.org/10.32007/jfacmedbagdad.6512014

Keywords:

Off-label drug, unlicensed drugs, neonates, neonatal care unit, Drug Labeling

Abstract

Background: Neonates who are admitted to hospitals will need various drugs. The use of unlicensed or off-label drugs without scientific evidence makes this exposure unsafe.

Aim of study: We aimed to assess the use of drugs for neonates based on the British National Formulary for Children and IBM Micromedex Neofax.

Patients and methods: This is a descriptive study which reviewed the clinical files of enrolled neonates who have stayed in the hospital for more than 24 hours and received at least one drug. It was conducted in the neonatal care unit of the Children Welfare Teaching Hospital/ Medical City Complex in Baghdad during the period from 1st of January to 30th of June/2018. The data was entered on a predesigned format and analyzed by using the appropriate statistical methods.

Results: A total number of 1079 neonates were admitted to the NCU during the study period, of whom 967 were included in the current study with 597 (61.7%) males and 370 (38.3%) females. There were 424 (43.8%) preterm, 496 (51.3%) term and post term neonates, and 47 (4.9%) neonates with unknown gestational age. Different classes of drugs were used with a total of 56 drugs, of which 33.9% were unlicensed and 66.1% were off-label. Accordingly, 42.5% of the neonates received unlicensed drugs and almost all patients received at least one off-label drug. Major risk factors for such use include mechanical ventilation, male sex and prolonged hospitalization.

Conclusions: In hospitalized neonates, drugs were more frequently prescribed as an off-label rather than unlicensed. Almost all neonates were exposed to off-label formulations.

Downloads

Download data is not yet available.

References

Bhartiy SS, Shinde M, Nandeshwar S, Tiwari SC 2008. Pattern of prescribing practices in the Madhya Pradesh, India. Kathmandu University Medical Journal (KUMJ); 6 (1): 55 - 9.

American Academy of Pediatrics. Policy Statement: Off label use of drugs in children. Pediatrics 2014; 133(3):563-7.

Giglio N. (2012). Pediatric pharmacology and use of unapproved drugs (off label). Arch Argent Pediatr; 110(1):4-7.

Choonara I. (2004). Unlicensed and off-label drug use in children. Implications for safety. Expert opin drugs saf; 3(2):81-3.

Bonati M, Brambilla C, Colombo F, Tognoni G, Bergher C, Bottino S, et al. Early neonatal drug utilization in preterm newborns in neonatal intensive care units. Italian Collaborative Group on Preterm Delivery. Dev Pharmacol Ther. 1988; 11:1-7. doi: 10.1159/000457657.

Glacola GP, Taylor Zapata P, Zajicek A. 2012. Drug studies in newborns; a therapeutic imperative. Perinatology; 39 (1):11 - 23

Brijal SP, Amita RK, Divyesh BS, Kiran GP. (2015). Drug utilization study in neonatal intensive care unit at tertiary care hospital, Rajkot, Gujarat: A prospective study. World J Pharm Sei; 4(7):2034-42.

Hines RN, McCarver DG. 2002. The ontogency of human drug-metabolizing enzymes: phase 1 oxidative enzymes. J pharmacol Exp Ther.; 300:355-360.

McCarver DG, Hines RN. 2002. The ontogeny of human drug metabolizing enzymes; phase 2 conjugation enzyme and regulatory mechanism. Journal of pharmacological Expermental Therapy; 300: 361 - 366.

Dresser R, Frader J. (2009). Off-label prescribing; a call for heightened professional and government oversight. Journal of Law Medical Ethics; 37:476-486.

Dell’Aera M, Gasbarro AR, Padovano M, Laforgia N, Capodiferro D, Solarino B, et al. (2007). Unlicensed and off label use of medicines in a neonatology clinic in Italy. Pharm World Sci.; 29(4):361-7.

Conroy S. (2011). Association between license status and medication errors. Arch Dis Child; 96:305-6.

Carvalho PRA, Carvalho CG, Alievi PT, Martinbiancho J, Eliana A. Trotta EA (2003). Prescription of drugs not appropriate for children in a Pediatric Intensive Care Unit. J pediatr (Rio J); 79:397-402.

Kimland E, Bergman U, Lindeman S, Bottiger Y. (2007). Drug related problems and off label drug treatment in children as seen at a drug information Centre. Europian Journal of pediatrics; 166: 527- 532.

Neubert A, lkas K, Leis T, Dormann H, Brune K, Rascher W. 2010. Drug utilization on a preterm and neonatal care unit (Germany): a prospective, cohort-based analysis. Europian Journal of Clinical Pharmacology; 66:87 - 95.

European Medicines Agency. (2013) Report on the Survey of all Pediatric Uses of Medicinal Products in Europe. EMA/794083/2009. Available at: http://www.ema.europa.eu, last access: 9 August 2013.

Mazhar F, Akram S, Haider N, Abdul Hadi M, Sultana J. (2018). Off‑label and unlicensed drug use in hospitalized newborns in a Saudi tertiary care hospital: a cohort study. International Journal of Clinical Pharmacy, Published as on line at 2018 may 2, https://doi.org/10.1007/s11096-018-0630-z

Al-Alaiyan SAR, Al-Ghamdi N. (2016). Neonatal Dosage and Practical Guidelines Handbook, 2nd Edition, 2016. LD no. 1435/3068, ISBN 978-603-8144-84-8

Abdul Rassoul AA, Wayyes ARM, Al-Ismaeli HK, Al-Rekabi MD. Alphabetical listing of Medicines. Iraqi Medicines Guide, 2016.

British National formulary, BNFC for children September 2017-2018

IBM micromedex Neofax 2018, 31 Edition. A manual of drugs used in Neonatal Care. Thomson Reuters.

Kumar P, Walker JK, Hurt KM, Bennett KM, Grosshans N, Fotis MA. (2008). Medication use in the neonatal intensive care unit: current patterns and off-label use of parenteral medications. J Pediatr. ; 152(3): 412-5.

Warrier I, Du W, Natarajan G, Salari V, Aranda J. (2006). Patterns of drug utilization in a neonatal intensive care unit. J Clin pharmacol; 46:449-455

Carvalho CG, Ribeiro MR, Bonilha MM, Fernandes Jr M, Procianoy RS, Silveira RC. (2012). Use of off label and unlicensed drugs in the neonatal intensive care unit and its association with severity scores. J pediatr (Rio J); 88(6):465-70.

Lass J, Kaar R, Jogi K, Varendi H, Metsvaht T, Lutsar I. Drug utilization pattern and off label use of medicines in Estonian neonatal units. Eur J Clin pharmacol; 67(12):1263-71.

Kieran EA, O’Callaghan N, O’Donnell cpf 2014. Un-licensed, off label drug use in Irish neonatal care unit; a prospective cohort study Acta Paediatrica; 103: e139-42.

Chatterjess S, Mandal A, Lyle N, Mukherjee S, Singh AK 2007. Drug utilization study in a neonatology unit of a tertiary care hospital in eastern India. Pharmaco-epidemiological Drug Safety; 16 (10):1141-5.

Liem TB, Krediet TG, Fleer A. (2010). Variation in antibiotic use in neonatal intensive care units in Netherlands. J Antimicrob Chemother.; 65(6):1270-5.

Coelho H, Rey LC, Barbosa RA. (2013). A critical comparison between the world health organization list of essential medicines for children and the Brazilian list of essential medicines. J Pediatr; 89(2):171-8.

Zisovska E, Koshi B, Slaveska R (2016). A study of off label and un-licensed medicines use in neonatal care units. Macedonian pharmaceutical bulletin 62 (2) 65-72.

Ballard CD, Peterson GM, Thompson AJ. 2013. Off-Label use of medicines in pediatric patients at Australian hospital. J Pediatrics and child health 49 (1):38 - 42.

Cuzzolin L, Atzei A, Fanos V. 2006. Off-label and un-licensed prescribing for newborns and children in different settings; a review of the literature and a consideration about drug safety. Expert Opinion in Drug Safety; 5 (5):703 - 18.

Cuzzolin L. Off-label drug in the newborn. Journal of Pediatric and Neonatal Individualized Medicine 2014; 3(2):e030224